Ellebaek, E., Khan, S., Borch, T., Guldbrandt, L., Friis, R., Schmidt, H., . . . Donia, M. (2024). 1109P Association of clinical features with long-term survival in patients with melanoma who responded to distinct checkpoint inhibitors. Annals of Oncology, 35, S734. https://doi.org/10.1016/j.annonc.2024.08.1177
Chicago Style (17th ed.) CitationEllebaek, E., et al. "1109P Association of Clinical Features with Long-term Survival in Patients with Melanoma Who Responded to Distinct Checkpoint Inhibitors." Annals of Oncology 35 (2024): S734. https://doi.org/10.1016/j.annonc.2024.08.1177.
MLA (9th ed.) CitationEllebaek, E., et al. "1109P Association of Clinical Features with Long-term Survival in Patients with Melanoma Who Responded to Distinct Checkpoint Inhibitors." Annals of Oncology, vol. 35, 2024, p. S734, https://doi.org/10.1016/j.annonc.2024.08.1177.